Fritextsökning
Innehållstyper
-
Nanexa develops depot formulation of the diabetes and obesity drug Saxenda
Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...
-
Setback for pharmaceutical companies in the Zantac case
A Delaware judge has ruled in favour of allowing expert witnesses to testify in a case involving the now-cancelled drug Zantac and its potential carcinogenicity.
-
Halv framgång för nytt ALS-läkemedel
Ett nytt läkemedel mot en sällsynt form av ALS rekommenderas av en rådgivande panel till FDA för ett villkorat godkännande i USA.
-
Bioarctic granted Japanese patent for Parkinson’s disease candidate
Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.
-
Swedish and Ukrainian Medical Product Agencies sign an agreement
The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.
-
Eventuell koppling mellan covidvaccin och dödsfall granskas
Läkemedelsverket utreder 280 fall av misstänkta biverkningar av covid-19-vaccin i samband med dödsfall.
-
Collaboration in laboratory automation
The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...
-
The fast route to a safe insulin pen
Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...
-
Mathias Uhlén’s protein atlas is recognised as a global resource
The Human Protein Atlas is the first database in Sweden to be designated a Global Core Biodata Resource. According to Mathias Uhlén, this is a quality hallmark ...
-
Gothenburg-based company acquired by Norwegian diagnostics group
Gentian Diagnostics acquires Gothenburg-based Getica.
-
Life Science-podden: The perfect moment for an IPO
When is the right time to go for an IPO? What strategy is recommended in today´s rather uncertain business climate when it comes to taking your life science company public?
-
Långtidscovid hos barn och unga får definition
Brittiska forskare har tagit fram en definition av vad som ska räknas som långtidscovid hos barn och ungdomar – något som kan underlätta forskning kring tillståndet.
-
Anna Törner: ”Orphan Designation – the "petite robe noire" of drug development”
It is easy to cling to various regulatory incentives, like orphan designation, and other expedited pathways, without understanding what they truly mean or wheth...
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...
-
Ny larmrapport: Över en miljon dör på grund av resistens mot antibiotika
En bra bit över en miljon dödsfall i världen orsakades av antibiotikaresistens under 2019, enligt en analys av globala data från 204 länder.
-
Just four weeks to a concept for an emergency ventilator
The lockdown in spring 2020 meant that the majority of Festo employees had to join the ranks of those working from home. Yet within the space of just four weeks...
-
Automated opening and closing of sample vials
From technical requirements to a suitable solution
-
ZEISS presents the "Quality Innovation Days"
The digital event for metrology and software.
-
Novartis utvecklar astma-app
Ett nytt samarbete mellan läkemedelsföretaget Novartis och hälsobolaget Medituner ska leda till bättre behandling vid svår astma.
-
Assignment: Facilitate the retention of foreign researchers
A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.
-
För tidigt att häva restriktionerna enligt ECDC
Europeiska smittskyddsmyndigheten, ECDC, varnar för att häva coronarestriktionerna för tidigt, eftersom det riskerar att leda till onödigt stor belastning på vården.
-
Trends and overview: ELRIG "Robotics and Automation"
Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic
-
The art of building a biologic drug
The first biosimilar from Xbrane Biopharma was launched earlier this year, and several more are under development at the company’s facility in Solna, Sweden. “W...
BREAKING